2022
DOI: 10.1016/j.freeradbiomed.2022.08.043
|View full text |Cite
|
Sign up to set email alerts
|

The selenoprotein methionine sulfoxide reductase B1 (MSRB1)

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
20
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 19 publications
(22 citation statements)
references
References 146 publications
1
20
0
Order By: Relevance
“…MSRB1 is responsible for reducing methionine sulfoxide (MetO) to methionine (Met). It supports a wide variety of cellular functions and recent reports elucidated a role for MSRB1 in the innate immune response [ 56 ]. The DIOs collectively regulate thyroid hormone activity [ 57 ].…”
Section: Overview Of Selenium In Biological Functionsupporting
confidence: 61%
“…MSRB1 is responsible for reducing methionine sulfoxide (MetO) to methionine (Met). It supports a wide variety of cellular functions and recent reports elucidated a role for MSRB1 in the innate immune response [ 56 ]. The DIOs collectively regulate thyroid hormone activity [ 57 ].…”
Section: Overview Of Selenium In Biological Functionsupporting
confidence: 61%
“…A higher Se transfer to eggs was observed when OH-SeMet was compared to SS ( Zorzetto et al, 2021 ), and also when compared to SY ( Jlali et al 2013 ). This generates a greater antioxidant capacity for the bird – as previously pointed out – and for the eggs themselves, thus ensuring not only higher quality eggs for longer storage periods – justified by the increased presence of selenoprotein MsrB1 ( Tarrago et al 2022 ) which promotes lower oxidation of egg protein – but also Se-rich eggs.…”
Section: Discussionmentioning
confidence: 77%
“…Lastly, as described above, the sites that the MICALs modify on actin (Met44 and/or Met47) have been linked to different diseases, including nemaline myopathy, CAP myopathy, aortic aneurisms, hypertrophic cardiomyopathy, intestinal hypoperistalsis, Baraitser-Winter cerebrofrontofacial syndrome, and ductus arteriosus (Laing et al, 2009;Hung et al, 2010b;Hoffjan et al, 2011;Zou et al, 2013;Regalado et al, 2014;Wangler et al, 2014;Yates et al, 2017;Zhang et al, 2019). It is also worth considering that some of the defects associated with mutations in the family of enzymes that reverse the MICAL's effects, MsrBs/SelR's, may result from increased effects of the MICALs on F-actin [see (Tarrago et al, 2022) for coverage of those defects].…”
Section: Figurementioning
confidence: 99%